Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27629,108,1.21 [0.99-1.49],0.0658001329751091
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28202,147,1.15 [0.96-1.36],0.1300503882801234
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27953,1008,1.07 [1.00-1.14],0.0636925749655072
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,28237,309,1.10 [0.97-1.24],0.1420603110977102
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27446,2786,1.06 [1.02-1.11],0.003700463057877
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27689,2089,1.06 [1.01-1.11],0.0218279921392524
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28024,1002,1.08 [1.01-1.16],0.021246959175129
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28149,44,1.00 [0.72-1.38],0.9763966056356708
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26962,645,1.11 [1.02-1.21],0.0164720849616791
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26080,626,1.14 [1.05-1.24],0.0027181487911662
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26317,174,1.17 [1.00-1.38],0.0535205468557369
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21034,1212,1.11 [1.04-1.18],0.0013817101506386
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26072,286,1.18 [1.04-1.34],0.0084890303805098
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28189,1167,1.08 [1.02-1.15],0.0118614582615812
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,28297,369,1.06 [0.94-1.18],0.3421676990015259
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27563,618,1.13 [1.04-1.23],0.0047053765749328
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28236,715,1.13 [1.04-1.22],0.0037555448650162
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27171,149,1.13 [0.95-1.34],0.1785610631238176
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28339,31,1.44 [0.99-2.08],0.0557985000308655
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28144,623,1.09 [1.00-1.19],0.0400125957589386
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28178,73,1.19 [0.93-1.52],0.1653740698003312
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28241,176,1.24 [1.06-1.45],0.0081199920580796
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28225,160,1.22 [1.03-1.44],0.0186157299154497
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27277,332,1.10 [0.98-1.24],0.1175709535231227
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27189,244,1.02 [0.88-1.17],0.8196103296102508
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27103,81,1.09 [0.86-1.38],0.4876462683953144
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28311,55,0.92 [0.68-1.24],0.573513150639551
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28278,132,0.99 [0.82-1.20],0.9451318192970698
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,28191,45,0.80 [0.58-1.12],0.2002974538493663
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28197,51,1.18 [0.87-1.59],0.2887274227646713
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,28041,324,1.07 [0.95-1.21],0.2435623249753728
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28246,76,1.20 [0.94-1.53],0.1389729634470661
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28225,83,1.21 [0.96-1.52],0.1133488610999461
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12641,45,1.05 [0.76-1.44],0.7750221336659169
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28142,1203,1.00 [0.94-1.06],0.9098075337040252
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of meninges,28327,49,1.25 [0.92-1.69],0.1539990552954398
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28304,53,1.00 [0.74-1.35],0.9886755623405028
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28316,97,1.22 [0.99-1.51],0.0683718432040448
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of ovary,15635,99,1.02 [0.82-1.27],0.8650777506772562
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28332,280,0.94 [0.82-1.07],0.3300823190239796
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,28328,209,0.96 [0.82-1.11],0.575019550422606
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28271,58,0.95 [0.71-1.26],0.7019923750224389
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,28331,183,0.89 [0.76-1.05],0.1739434863097133
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,28294,297,0.98 [0.86-1.11],0.7083595033828263
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28263,558,0.95 [0.86-1.04],0.2417836262558645
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28332,315,0.97 [0.86-1.10],0.6704335883071249
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Carcinoma in situ of breast,13452,90,0.81 [0.64-1.03],0.0818645865602193
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13500,104,0.87 [0.70-1.09],0.2279128440773506
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24498,32,1.29 [0.90-1.86],0.1718655605738814
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24504,38,0.83 [0.58-1.19],0.3161510819209023
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28296,114,1.01 [0.82-1.24],0.9207578124181998
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",28296,112,1.01 [0.82-1.24],0.919602260630504
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,14989,424,0.96 [0.86-1.06],0.4118716743299765
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,21055,179,1.13 [0.95-1.33],0.162017061390557
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lymphoid leukaemia,24495,29,1.32 [0.90-1.95],0.1563010878427908
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24619,153,1.00 [0.84-1.19],0.9885728959599396
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24552,86,1.16 [0.92-1.45],0.2153076933409607
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13551,82,0.96 [0.76-1.23],0.7581355119532226
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24516,50,0.73 [0.53-1.00],0.0519061177785972
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24536,70,1.04 [0.80-1.35],0.7726560055476349
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24539,73,1.08 [0.84-1.39],0.5398969776237927
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13523,54,1.15 [0.86-1.54],0.3503024435908288
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24527,61,1.33 [1.02-1.75],0.0369953023042748
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11410,413,1.07 [0.96-1.19],0.2177199106508472
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24558,92,1.12 [0.89-1.40],0.3239260686329011
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24523,57,1.27 [0.96-1.68],0.0917968907597966
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24532,66,0.86 [0.66-1.13],0.2884671474249516
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,28089,215,0.98 [0.85-1.14],0.8235687204895089
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,28287,97,0.91 [0.73-1.14],0.425690010455317
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanoma in situ,24482,53,1.21 [0.90-1.63],0.1975449952215127
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24527,61,0.97 [0.74-1.29],0.8557922780221375
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24589,123,1.02 [0.84-1.24],0.8686568583802785
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24588,122,1.15 [0.94-1.39],0.1710867504443042
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24536,70,1.02 [0.79-1.33],0.8566521243473939
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,28151,145,1.07 [0.89-1.27],0.4790166502058699
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25122,656,0.99 [0.91-1.08],0.828847543741687
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25154,688,0.99 [0.91-1.08],0.8712327261432331
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28063,288,1.09 [0.96-1.24],0.1676166403062356
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26887,60,1.16 [0.88-1.53],0.3028120219977085
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27846,71,1.10 [0.85-1.41],0.475815206155136
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27522,2287,1.08 [1.03-1.13],0.0005579213278942
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27119,24,0.87 [0.55-1.37],0.5399563542738903
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27977,37,1.16 [0.82-1.65],0.400297482787489
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27886,1059,1.12 [1.04-1.19],0.0010856159276555
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27886,1059,1.12 [1.04-1.19],0.0010856159276555
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26886,59,1.00 [0.75-1.33],0.9931399046856187
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28047,952,1.13 [1.06-1.21],0.0004801253551693
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28056,116,1.06 [0.87-1.29],0.5774998005990262
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27830,55,1.15 [0.86-1.53],0.3489482038065449
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27817,42,1.28 [0.93-1.78],0.132972711108149
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28136,196,0.88 [0.76-1.04],0.1296142982599249
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28259,72,1.27 [0.99-1.62],0.0616417679472141
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28103,163,0.83 [0.70-0.99],0.0413303269024194
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27171,76,1.11 [0.86-1.42],0.4156772812188988
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24348,220,1.07 [0.93-1.24],0.3502756237516634
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26376,130,1.06 [0.88-1.28],0.5428051593808063
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26387,141,1.10 [0.91-1.32],0.3163322668573828
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24166,38,1.35 [0.96-1.89],0.0857866025733141
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26311,72,1.02 [0.79-1.32],0.8801177322596171
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25966,154,1.10 [0.93-1.31],0.2786314846695172
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28191,172,1.01 [0.86-1.19],0.8947757989610382
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,28067,48,0.84 [0.61-1.16],0.2934141172006366
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,28056,37,1.16 [0.81-1.64],0.4164219705708379
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27923,1684,1.06 [1.01-1.12],0.0250765114121758
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25389,1633,1.06 [1.01-1.12],0.0235349131809374
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24170,42,1.07 [0.76-1.49],0.7103551690377123
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26615,57,0.84 [0.63-1.13],0.2537813994863513
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24322,194,1.36 [1.17-1.59],5.177478428952561e-05
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24194,66,1.23 [0.95-1.59],0.1233091618726376
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26580,2452,1.15 [1.10-1.20],2.9345390106060913e-10
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24249,121,1.09 [0.90-1.33],0.3775204162172169
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24528,400,1.20 [1.08-1.33],0.0009836207097222
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28235,282,1.23 [1.08-1.39],0.0013219790138027
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,28070,117,1.42 [1.17-1.72],0.0003215119758511
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24229,101,1.07 [0.87-1.33],0.5191356009871619
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24166,38,1.11 [0.78-1.58],0.5485537344443476
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27900,1342,1.09 [1.03-1.16],0.0026772660079159
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24262,134,1.23 [1.02-1.48],0.0300096175875582
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24298,170,1.06 [0.90-1.25],0.513997065700635
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24528,400,1.13 [1.01-1.26],0.02736735048669
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24190,62,1.10 [0.84-1.45],0.4854722328028992
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,28063,110,1.41 [1.16-1.72],0.0006916681732258
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24432,304,1.12 [0.99-1.27],0.0686955973814539
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24427,299,1.09 [0.96-1.24],0.1677375379656647
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25870,58,1.20 [0.91-1.58],0.1924157336277832
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27632,3504,1.13 [1.09-1.17],1.6355909419794368e-10
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26596,38,1.00 [0.70-1.42],0.9975554432696236
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26617,59,1.09 [0.82-1.44],0.54634658145869
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28150,1976,1.00 [0.95-1.05],0.938847824895174
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28154,1973,1.00 [0.95-1.05],0.9512227146071026
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26596,38,1.49 [1.07-2.09],0.0182558822412456
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,28007,1272,1.07 [1.01-1.14],0.0327539762722745
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25046,918,1.11 [1.04-1.19],0.0032889492691642
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28329,141,0.99 [0.82-1.19],0.921094269387722
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28053,34,0.88 [0.60-1.28],0.5039089072563947
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26826,91,1.08 [0.86-1.35],0.5150247960352219
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26856,121,1.17 [0.96-1.42],0.1224809778969173
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24263,135,1.41 [1.18-1.68],0.0001750805124575
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26495,119,1.12 [0.92-1.36],0.2580688579112649
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1750,72,0.97 [0.75-1.25],0.8106515609865133
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1860,197,0.99 [0.85-1.16],0.9317610431852112
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26416,40,1.01 [0.73-1.41],0.9360865616053002
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1714,36,1.25 [0.88-1.77],0.216940068706773
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27907,1531,1.10 [1.04-1.16],0.0007633226112434
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28091,72,0.95 [0.74-1.23],0.7213499299248467
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26090,278,1.04 [0.91-1.18],0.5857571838300277
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24548,420,1.16 [1.05-1.29],0.0052558501357953
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28251,180,1.04 [0.88-1.22],0.6482595767669737
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27590,58,0.98 [0.73-1.30],0.865297984092604
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,27032,813,1.04 [0.96-1.12],0.3124139008155406
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27637,105,1.05 [0.86-1.30],0.6175003208023706
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27563,31,1.51 [1.04-2.20],0.0299803286643069
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27640,108,1.17 [0.96-1.44],0.126341364316132
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20226,967,1.06 [0.99-1.14],0.087659283178534
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,AV-block,25788,190,0.98 [0.83-1.14],0.7598344783294748
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28305,267,0.90 [0.78-1.02],0.1083951114870853
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,19377,118,1.21 [1.00-1.47],0.0534242474095616
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25736,138,1.00 [0.83-1.20],0.9686700455863668
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25681,83,0.96 [0.75-1.22],0.7351821147639381
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28341,21,0.60 [0.36-1.00],0.0518781887836711
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,26147,549,1.00 [0.92-1.10],0.9157861542052728
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27598,1390,1.13 [1.07-1.20],3.123012489052876e-05
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26350,6170,1.07 [1.05-1.10],3.0009583740323176e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27156,188,1.03 [0.88-1.21],0.6937827478638932
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Endocarditis,25643,45,0.81 [0.58-1.13],0.2104760608477849
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28223,532,1.11 [1.01-1.21],0.0341832481629513
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,26945,5023,1.08 [1.05-1.11],4.5596445114802034e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26962,5040,1.08 [1.05-1.11],3.800622162699553e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28170,60,0.78 [0.58-1.03],0.0842061563986764
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22010,88,0.94 [0.75-1.19],0.61952250053391
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21990,68,1.25 [0.97-1.61],0.0846685017796404
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,28232,703,1.04 [0.96-1.13],0.3459839489859405
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27799,65,1.09 [0.84-1.43],0.5115870703349998
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27765,1546,1.11 [1.05-1.17],0.000275969697307
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28105,312,1.09 [0.96-1.23],0.1713530899626403
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25796,198,1.12 [0.97-1.31],0.1319331951320451
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28075,614,1.09 [1.00-1.19],0.0566030721715591
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26719,500,1.11 [1.01-1.22],0.0310710717489714
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28282,124,1.00 [0.82-1.21],0.9669598761039272
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28324,207,1.11 [0.95-1.29],0.1780424902071648
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,27009,41,0.75 [0.53-1.06],0.1075807211970993
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,27584,52,0.87 [0.64-1.19],0.3890065327541457
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25842,244,0.98 [0.85-1.13],0.787925379753581
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27598,66,1.34 [1.04-1.74],0.0240492411043499
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27680,148,0.98 [0.82-1.17],0.8210054452433957
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25729,131,1.00 [0.83-1.21],0.9764030110876348
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,27041,73,0.91 [0.70-1.18],0.4675433186869424
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,27018,50,1.29 [0.96-1.74],0.0886300884926606
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27545,39,1.08 [0.77-1.52],0.65659941443398
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,27060,92,0.94 [0.75-1.19],0.6260719969824509
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26199,601,1.07 [0.98-1.16],0.1573619996177369
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27578,49,0.90 [0.65-1.23],0.4970547592652877
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27878,346,1.17 [1.04-1.31],0.0089118554949141
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27889,157,1.06 [0.89-1.26],0.5237752688806429
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27747,241,1.01 [0.88-1.16],0.8746099146212754
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19516,257,0.97 [0.85-1.11],0.6826426953807303
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27717,211,1.17 [1.01-1.35],0.0409707840813378
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27230,262,1.09 [0.95-1.24],0.2091263836037873
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28071,339,1.10 [0.98-1.24],0.101346192233297
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28300,340,1.06 [0.94-1.19],0.3268588077116074
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25781,183,0.91 [0.78-1.07],0.2690672145485426
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27885,153,1.05 [0.88-1.25],0.591272956873056
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27625,119,1.10 [0.90-1.34],0.3388460927954213
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28099,365,1.08 [0.97-1.21],0.1684852146522263
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28072,401,1.06 [0.95-1.18],0.3209165312194105
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27773,54,0.95 [0.70-1.27],0.7126503919379674
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27586,55,0.90 [0.67-1.21],0.4845413077045806
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27939,146,1.04 [0.87-1.25],0.6447172178901206
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27645,184,1.09 [0.93-1.28],0.2907820817520513
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,27295,327,0.92 [0.81-1.04],0.1610692773212747
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27541,48,1.01 [0.73-1.38],0.9680839576210836
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28166,542,1.09 [0.99-1.19],0.0700333111630756
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28179,384,1.04 [0.93-1.16],0.5389703071636349
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25274,1462,1.08 [1.02-1.14],0.0074777111898781
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,27572,3760,1.05 [1.02-1.09],0.0036255073980168
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28117,457,1.03 [0.93-1.14],0.5290663998025209
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25524,1712,1.06 [1.00-1.11],0.0353693914592916
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23907,95,0.99 [0.79-1.24],0.905963176483372
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,27790,1549,1.04 [0.98-1.10],0.1674075346741697
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25613,1801,1.04 [0.99-1.10],0.1164614664354204
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Vascular dementia,28224,22,1.01 [0.64-1.60],0.9665353099105716
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,28342,67,0.89 [0.68-1.17],0.4045355368529323
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Bell's palsy,26639,77,0.99 [0.78-1.27],0.9640099833231018
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27049,487,1.03 [0.93-1.13],0.6010079463147141
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,27981,212,1.06 [0.91-1.23],0.442098387881216
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28255,232,1.06 [0.92-1.22],0.406686055677566
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28195,23,0.99 [0.63-1.56],0.9711864318684182
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28326,53,1.24 [0.93-1.66],0.1490276037131807
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27830,61,0.87 [0.66-1.15],0.3290884927517654
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,26731,264,0.99 [0.87-1.13],0.8701034974910149
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27845,1378,1.04 [0.98-1.10],0.2246546787227847
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28311,274,1.02 [0.90-1.17],0.7148800928021104
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27808,1679,0.99 [0.94-1.05],0.7420873378078492
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,27962,54,1.17 [0.88-1.55],0.2926286748761144
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,28189,166,1.06 [0.89-1.25],0.5192597763738793
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,27815,46,1.41 [1.04-1.91],0.0263736471482991
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28317,66,1.28 [0.99-1.66],0.0597561013985156
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26643,81,0.92 [0.72-1.18],0.5333438541683683
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26649,87,1.21 [0.97-1.52],0.0967222562394259
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Memory loss,28187,74,0.86 [0.67-1.12],0.2661040085399855
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,26900,433,1.07 [0.97-1.19],0.1952143236726973
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28249,385,1.07 [0.95-1.19],0.2583648076245272
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,20642,97,1.18 [0.95-1.46],0.1386567098001319
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28138,147,1.00 [0.84-1.20],0.9822795381397168
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27721,1159,1.07 [1.00-1.13],0.0507294285250084
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,26882,3153,1.04 [1.00-1.08],0.0550587449768783
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28249,77,1.12 [0.87-1.43],0.377169335736219
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26960,398,1.10 [0.99-1.23],0.0721574644067229
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28268,243,1.08 [0.94-1.24],0.2604731384761806
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23645,314,1.02 [0.90-1.15],0.7299721686764868
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27828,59,0.94 [0.71-1.25],0.6564642614314051
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27885,116,0.89 [0.72-1.09],0.2597347577728361
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28130,93,1.11 [0.88-1.38],0.3800640926605737
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26657,95,0.99 [0.80-1.24],0.9629410470484
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,26529,62,1.25 [0.95-1.63],0.1055401640598133
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,28216,447,1.07 [0.97-1.19],0.1870241412168979
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,27067,600,1.02 [0.93-1.11],0.6620213082865588
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,28329,160,0.96 [0.81-1.14],0.6110621069379032
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27835,66,1.11 [0.85-1.44],0.4544808485486143
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,28340,47,1.20 [0.88-1.65],0.2460392246247994
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,28090,523,1.03 [0.93-1.13],0.5879595127166903
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,28063,38,1.50 [1.08-2.08],0.016152920709594
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28326,123,1.14 [0.94-1.38],0.1870805141129214
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26594,32,1.09 [0.75-1.60],0.6463364411684576
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28342,68,0.92 [0.71-1.20],0.5545511462450415
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28211,21,1.02 [0.64-1.63],0.936387687158809
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27851,43,1.09 [0.78-1.51],0.6145618438334719
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27984,219,0.94 [0.81-1.10],0.450136361941283
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28249,198,1.02 [0.87-1.19],0.8058978150890337
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27580,37,0.95 [0.66-1.36],0.7673830441724256
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27620,77,1.10 [0.86-1.41],0.4319108940465453
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28251,30,1.10 [0.74-1.63],0.6268599600296207
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28135,63,1.14 [0.87-1.49],0.356604664166509
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1721,43,1.46 [1.06-2.00],0.020073065286745
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2033,89,1.03 [0.82-1.29],0.8134564634026022
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27885,77,1.03 [0.81-1.32],0.7884538235013016
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28210,633,0.99 [0.91-1.08],0.8275705564456072
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28033,490,0.96 [0.87-1.06],0.3782388296572849
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27682,139,0.91 [0.76-1.10],0.3420168636876529
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28246,481,1.03 [0.93-1.13],0.6187295557281554
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28328,55,0.75 [0.55-1.01],0.0598419069036858
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28171,406,1.02 [0.91-1.13],0.7619461046829925
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28297,225,1.06 [0.92-1.23],0.4195828076119106
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28278,131,0.95 [0.79-1.15],0.6003040297169329
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27560,17,0.92 [0.54-1.56],0.751176333432348
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27572,29,1.18 [0.80-1.75],0.4007715334687436
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27576,33,0.72 [0.48-1.07],0.1013419792408772
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28290,393,1.02 [0.92-1.14],0.7021620867392766
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27997,100,0.91 [0.73-1.13],0.4062394348733196
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27791,26,1.38 [0.92-2.08],0.1209453088621687
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28148,76,1.17 [0.91-1.49],0.216792423932766
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28221,149,1.01 [0.84-1.21],0.9126697343319856
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27927,162,1.06 [0.89-1.25],0.5113493578858502
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28224,77,1.03 [0.80-1.32],0.8166442496069718
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28158,261,1.11 [0.97-1.26],0.1353868015704002
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27929,121,1.13 [0.93-1.37],0.2127897527065036
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27618,1078,1.07 [1.00-1.14],0.0518262344429288
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28196,124,1.01 [0.83-1.23],0.9149806647310654
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28315,114,1.05 [0.86-1.29],0.615425133283032
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27814,271,1.00 [0.87-1.14],0.9828527854205604
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28111,39,1.06 [0.75-1.50],0.7401173183945358
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28311,38,0.73 [0.51-1.06],0.0957478698211888
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27584,41,0.99 [0.71-1.40],0.9649236746951564
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27664,121,1.00 [0.82-1.22],0.9747942188250048
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27649,72,0.82 [0.63-1.07],0.138926277431593
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27826,61,1.12 [0.85-1.47],0.4288063249686599
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27628,51,0.82 [0.60-1.12],0.2064364035893235
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27955,58,1.12 [0.84-1.48],0.4456968269176337
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27992,95,0.96 [0.77-1.20],0.7085225451900727
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27635,92,1.13 [0.91-1.41],0.278983671083302
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27701,124,1.20 [0.99-1.45],0.0589479651862388
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27614,37,0.95 [0.66-1.37],0.7940574741707365
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27389,849,1.02 [0.95-1.10],0.5852864515256384
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27593,50,0.80 [0.59-1.10],0.1771843727505738
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28122,314,1.09 [0.96-1.23],0.1779206617165254
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27845,37,0.89 [0.62-1.27],0.5165536028401674
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27938,130,1.04 [0.86-1.26],0.6788860603752435
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28150,61,0.80 [0.60-1.07],0.1267873228246967
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28299,99,1.03 [0.83-1.28],0.768958977478188
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28217,137,1.00 [0.83-1.21],0.9690039543585474
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28144,55,1.11 [0.84-1.49],0.4601560506955944
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28143,54,1.05 [0.78-1.41],0.7414073948863611
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28250,544,1.03 [0.94-1.13],0.5179750447179675
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28044,338,1.07 [0.95-1.20],0.2782552971664007
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27804,98,0.97 [0.78-1.21],0.7917770682156089
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27786,80,1.17 [0.92-1.48],0.2013974259683297
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,28045,82,0.77 [0.60-0.99],0.0376430599472997
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28203,240,0.86 [0.75-0.99],0.0391376819640918
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28028,65,0.87 [0.66-1.14],0.3167346739160503
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza,27007,80,1.06 [0.83-1.35],0.6473064945272536
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),27005,78,1.08 [0.84-1.37],0.5609726031441324
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),21003,127,1.02 [0.84-1.23],0.870111086577666
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,28188,319,1.14 [1.01-1.29],0.029423546786563
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22537,1806,1.06 [1.01-1.12],0.0158556510061905
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22654,1778,1.07 [1.02-1.13],0.0086003028700423
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28054,98,1.35 [1.09-1.66],0.0057654315378562
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26985,58,1.44 [1.09-1.89],0.0093787899189322
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,25219,188,1.26 [1.08-1.47],0.0035293940417924
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25074,43,1.10 [0.79-1.54],0.561232400811581
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27447,2416,1.06 [1.02-1.11],0.0051440411314972
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26832,70,0.97 [0.75-1.26],0.8380135815788464
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26934,172,1.20 [1.03-1.42],0.0231419624033594
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28234,732,1.03 [0.95-1.12],0.4274238625819263
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26893,131,1.10 [0.92-1.33],0.2976229590881059
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26373,4373,1.06 [1.03-1.10],0.0001981120396244
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27151,389,1.08 [0.97-1.20],0.1807049023647623
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,28016,514,1.02 [0.93-1.13],0.6175435725241927
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Emphysema,25223,192,1.21 [1.03-1.42],0.0185156786192036
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27067,118,1.11 [0.91-1.35],0.2989034216818993
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28155,1228,1.05 [0.99-1.12],0.1117986444109571
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,27093,144,1.13 [0.95-1.35],0.1696945099125773
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Later onset COPD,26872,218,1.06 [0.92-1.23],0.4217009124166685
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28333,158,1.01 [0.85-1.20],0.8901148440651689
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,26876,114,1.14 [0.93-1.39],0.1973789840000322
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28126,634,1.16 [1.06-1.26],0.0008139480717058
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,28162,1280,1.12 [1.06-1.19],0.0001329433649505
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27672,910,1.11 [1.04-1.19],0.0032905433180939
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,26916,34,1.08 [0.74-1.55],0.6989313552525735
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28288,204,1.05 [0.91-1.23],0.4929726307467734
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28259,870,1.15 [1.07-1.24],0.0001119433262662
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,27492,610,1.12 [1.03-1.22],0.0089725888939049
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural plaque,26938,56,1.09 [0.82-1.45],0.5700197722009934
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27942,1015,1.04 [0.97-1.11],0.2598901987651384
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28313,138,1.03 [0.86-1.24],0.7274409806423722
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumothorax,26947,65,1.32 [1.02-1.71],0.0336632914177228
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pollen allergy,28307,273,1.11 [0.98-1.26],0.1131302636390625
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,28123,39,0.90 [0.63-1.28],0.5599880857723001
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20914,38,1.13 [0.79-1.62],0.5006003818225526
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28106,614,1.15 [1.05-1.25],0.0016604381616168
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27081,319,1.14 [1.02-1.29],0.0260016817084446
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,27122,195,1.06 [0.91-1.24],0.4344061202118355
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28073,167,1.01 [0.85-1.19],0.9320688241096124
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16354,106,1.04 [0.84-1.28],0.7409636509109856
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21701,67,0.97 [0.74-1.26],0.807972187223977
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,28137,159,0.92 [0.77-1.10],0.3569392689521534
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute gastritis,22634,74,0.92 [0.71-1.19],0.5081995786407875
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,26718,169,1.03 [0.87-1.22],0.7334474052672711
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,27896,77,1.16 [0.91-1.47],0.2376727234444054
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27537,85,0.86 [0.67-1.09],0.2069534824150977
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,22920,360,1.03 [0.92-1.15],0.6380149377075245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26605,56,1.04 [0.78-1.38],0.8081814224191592
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27924,56,1.04 [0.78-1.38],0.8108142946228081
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,26735,186,1.02 [0.87-1.20],0.7629954196185951
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,27473,924,1.03 [0.96-1.11],0.3844617235097793
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,22828,268,1.10 [0.96-1.25],0.1759121376775584
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26590,41,1.16 [0.83-1.61],0.3820643733506899
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28191,81,0.85 [0.66-1.08],0.1877321298448162
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,26879,121,1.05 [0.86-1.27],0.6551878026980466
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,26733,60,1.21 [0.92-1.59],0.1755833990957138
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28152,216,0.96 [0.83-1.12],0.6195602386856565
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,28111,1214,1.04 [0.98-1.11],0.1743560137182008
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,26768,95,1.05 [0.84-1.31],0.6708647226728756
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27985,67,1.11 [0.85-1.44],0.4431602872266955
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26766,93,1.08 [0.86-1.34],0.5219844497949652
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,27482,269,1.11 [0.98-1.27],0.1046152316597697
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26221,1878,1.03 [0.98-1.08],0.2749867444870467
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,28181,203,0.99 [0.85-1.16],0.9418476204612404
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,28221,769,1.04 [0.96-1.13],0.2929895874383489
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26585,4025,1.02 [0.99-1.06],0.2635306835237837
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27844,631,1.09 [1.00-1.19],0.0396220838286487
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28264,445,1.17 [1.06-1.29],0.0024389785949707
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27349,136,1.08 [0.90-1.29],0.434753944472791
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27181,73,1.04 [0.81-1.34],0.7381358452616127
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28051,1293,1.05 [0.99-1.11],0.139963682662495
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,27195,124,0.98 [0.81-1.19],0.8498971105182248
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27820,1271,1.03 [0.97-1.09],0.3495358219769967
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24140,2506,1.06 [1.02-1.11],0.0072230204976153
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22706,146,1.05 [0.87-1.25],0.6201891766014125
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28269,116,1.01 [0.82-1.23],0.957119519324966
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28200,83,1.24 [0.98-1.56],0.0720429669947162
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27556,104,0.90 [0.73-1.12],0.355105419478638
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21820,186,0.94 [0.80-1.10],0.4565832019947264
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,23087,527,1.01 [0.92-1.11],0.79061838884242
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,22850,290,0.98 [0.86-1.11],0.723766770950828
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24884,2324,1.06 [1.01-1.11],0.0147027499582005
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22977,417,0.99 [0.89-1.11],0.8980377387771219
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23163,8308,1.02 [1.00-1.05],0.0633969575166227
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,27797,1039,1.01 [0.95-1.08],0.7139900120514517
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27275,62,1.17 [0.89-1.53],0.2659318236684502
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22586,1322,1.09 [1.03-1.16],0.002462515591242
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27507,55,1.07 [0.80-1.44],0.6377913823730192
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,27158,2815,1.01 [0.97-1.05],0.6383011506959507
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,28209,77,1.35 [1.06-1.71],0.0132253238427659
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,21668,34,1.41 [0.99-2.00],0.0580683722623467
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,25039,696,0.99 [0.91-1.08],0.8361989702636837
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24424,81,0.92 [0.72-1.17],0.480533009883908
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21710,76,0.95 [0.74-1.22],0.6806151877944342
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26900,142,1.15 [0.96-1.38],0.1228426069115314
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22218,584,1.06 [0.97-1.16],0.2078782476997006
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28315,402,1.10 [0.99-1.22],0.0914517882670905
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27397,724,1.06 [0.97-1.14],0.1869704881609242
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27588,915,1.09 [1.02-1.17],0.014132760446806
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22714,154,1.18 [1.00-1.40],0.0543491212786799
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,23062,502,1.07 [0.97-1.18],0.1592613203222619
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28297,135,0.99 [0.82-1.19],0.8985369815614692
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24396,53,1.16 [0.87-1.56],0.3165062870988874
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22960,1326,1.03 [0.97-1.09],0.3947394087039636
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26752,203,1.00 [0.86-1.17],0.9522463806345132
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26713,164,0.96 [0.81-1.14],0.6602285152368006
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,23175,1541,1.01 [0.95-1.07],0.742073080543513
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,26659,5025,1.03 [1.00-1.06],0.0367540384494923
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27187,202,0.99 [0.85-1.16],0.9258193179557936
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,28076,624,1.03 [0.94-1.12],0.5386441362728245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23114,554,1.03 [0.94-1.13],0.4796056492400417
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26635,86,1.04 [0.82-1.31],0.7697739152365642
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28204,385,1.17 [1.05-1.30],0.0048640193221275
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23374,814,0.98 [0.91-1.06],0.5765861617801915
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27811,1053,1.02 [0.95-1.09],0.6155968954216187
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27407,194,1.16 [0.99-1.35],0.0649122132930915
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22897,1263,1.05 [0.99-1.11],0.1246760599493656
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24397,1837,1.01 [0.96-1.06],0.7952045716727142
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27536,84,0.94 [0.74-1.19],0.5986195723212604
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27473,800,1.05 [0.98-1.14],0.1874627101252507
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21870,236,1.11 [0.97-1.28],0.1366140416121647
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28184,98,1.21 [0.98-1.50],0.0798131473548485
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21989,355,1.05 [0.93-1.17],0.4474724386322976
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26897,139,1.18 [0.99-1.41],0.0699827840440112
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28331,61,1.04 [0.79-1.37],0.7942149639308371
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27230,133,1.05 [0.87-1.26],0.6167188082539992
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Toxic colitis,26706,33,0.80 [0.54-1.18],0.2563125362420911
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22749,189,1.17 [1.00-1.36],0.0491778691799938
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26827,154,1.34 [1.13-1.58],0.0006239005570165
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26806,133,1.27 [1.06-1.52],0.0095825624603306
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,24631,288,0.91 [0.80-1.04],0.1579395438394104
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21738,104,1.15 [0.93-1.42],0.1900978502880539
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,24575,232,1.08 [0.94-1.25],0.2696205939065381
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Volvulus,21698,64,0.92 [0.70-1.21],0.5569053181354264
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28283,163,1.12 [0.94-1.32],0.1960985959462945
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28057,81,0.97 [0.76-1.24],0.791590852517577
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26820,150,1.01 [0.84-1.20],0.9338349006528924
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27700,562,1.02 [0.93-1.12],0.6688704555476617
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27342,204,1.13 [0.97-1.31],0.1112233803842051
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26849,179,1.15 [0.98-1.36],0.0828614391134374
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28071,235,1.13 [0.98-1.30],0.0939049912508261
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28239,403,1.11 [1.00-1.23],0.0568540103335023
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27886,50,1.31 [0.97-1.76],0.0763155145583428
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26835,2641,1.04 [1.00-1.08],0.0670891602336703
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27873,452,0.93 [0.84-1.03],0.1730621649754094
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27743,322,0.96 [0.85-1.08],0.4947363206543075
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27942,804,1.04 [0.97-1.12],0.2931843490923455
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28327,49,1.32 [0.98-1.78],0.0702845911321419
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26726,56,0.91 [0.68-1.22],0.5368064550128607
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27462,41,1.06 [0.76-1.48],0.7498304860969442
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28064,228,1.13 [0.98-1.30],0.0862274059497935
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26971,301,1.13 [1.00-1.28],0.0499635347520462
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26708,38,1.24 [0.88-1.74],0.2234081877942434
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28257,69,1.05 [0.81-1.36],0.7212374041116529
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27279,141,1.24 [1.04-1.48],0.0181764102120281
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28139,163,0.87 [0.73-1.04],0.1216385104720688
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27869,33,0.96 [0.65-1.41],0.8335826781749387
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26725,55,1.04 [0.78-1.40],0.7739447467667023
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27803,1133,1.04 [0.98-1.11],0.1845727292773943
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27001,331,1.16 [1.03-1.31],0.0113031041422754
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26712,42,1.31 [0.95-1.81],0.0947666099857781
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28253,277,0.98 [0.86-1.12],0.7690511428560177
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27899,63,0.93 [0.71-1.23],0.625398183846114
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28203,227,0.92 [0.79-1.06],0.2581919674893784
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28306,186,1.09 [0.93-1.28],0.2799566752050293
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26795,125,1.08 [0.89-1.31],0.421905315798978
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26864,194,0.98 [0.84-1.14],0.7638824783142482
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28296,176,1.09 [0.93-1.28],0.2906034989402936
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26802,132,1.03 [0.85-1.25],0.7378388008365963
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28308,120,1.04 [0.85-1.26],0.7197778530771849
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24886,136,1.09 [0.91-1.31],0.34514647097348
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26469,4787,1.01 [0.98-1.05],0.3536312323137255
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25050,3368,1.01 [0.98-1.05],0.5144207127967184
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24847,97,0.93 [0.75-1.17],0.5451683553334197
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25435,157,1.09 [0.92-1.29],0.3300630206822599
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25443,165,1.19 [1.01-1.41],0.0369187247076558
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28107,118,0.88 [0.72-1.08],0.2138645392694308
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25325,47,0.91 [0.66-1.26],0.5716964038445901
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22453,771,1.01 [0.94-1.10],0.7238967193139796
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28283,127,1.00 [0.82-1.21],0.9957870953164774
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25578,300,1.02 [0.90-1.16],0.735042561062335
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24799,6426,1.02 [0.99-1.04],0.2765741150422742
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26941,111,1.01 [0.82-1.24],0.9178715987672847
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24868,118,0.86 [0.70-1.06],0.1521153200546101
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25376,626,1.04 [0.95-1.13],0.4109731905766476
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27433,2155,1.03 [0.98-1.08],0.1953433124886323
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24982,232,1.12 [0.97-1.29],0.1116902289517722
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25040,290,1.18 [1.04-1.34],0.0092972486377507
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24906,156,1.17 [0.99-1.39],0.0680404316539986
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27817,36,1.03 [0.72-1.48],0.8648117458600384
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,23030,1348,1.02 [0.96-1.08],0.5051126345428375
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22089,407,1.09 [0.98-1.22],0.0931308689699943
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28286,397,1.10 [0.99-1.22],0.0816035863011078
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21753,71,1.08 [0.84-1.39],0.5643123317610477
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22035,353,0.92 [0.82-1.04],0.1849059946228832
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25089,339,0.95 [0.84-1.07],0.4074268938655386
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22476,794,1.01 [0.93-1.09],0.8759708135457827
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25307,29,0.88 [0.58-1.33],0.5400885688603534
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25848,570,1.11 [1.02-1.22],0.0194626110766629
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25568,290,1.08 [0.95-1.23],0.2157779140095907
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22422,740,0.99 [0.91-1.07],0.7620335581280514
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24838,88,1.19 [0.95-1.49],0.13293059784112
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24813,63,1.01 [0.77-1.33],0.9319344852524822
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26887,57,1.11 [0.84-1.47],0.4760916502090755
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27998,1168,1.02 [0.96-1.09],0.5147022733968896
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27490,660,1.05 [0.96-1.14],0.2940734035227242
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28230,359,1.11 [0.99-1.25],0.0634684521199192
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23489,1807,1.01 [0.96-1.07],0.6059342333059947
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21766,84,0.94 [0.74-1.19],0.5888479340932865
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24832,82,1.21 [0.96-1.54],0.1071733794715095
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21709,27,0.78 [0.51-1.20],0.2648686718442744
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21798,116,0.95 [0.77-1.16],0.6026611313198809
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27065,235,0.93 [0.80-1.07],0.2891552906456511
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27080,250,1.08 [0.94-1.24],0.2777154609234739
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28298,86,0.98 [0.78-1.24],0.8821649840238325
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26890,1612,1.07 [1.01-1.13],0.0151865322257959
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24871,121,0.88 [0.72-1.08],0.2202504779487178
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21798,116,0.81 [0.66-1.00],0.0538771592948245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25932,654,1.05 [0.97-1.14],0.2432059123097176
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23780,2098,1.01 [0.97-1.06],0.6226914264191705
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27841,60,1.02 [0.77-1.35],0.8823883806451955
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28314,77,1.02 [0.79-1.31],0.8852634377185076
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24836,86,1.15 [0.91-1.44],0.2500731359804878
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25880,1130,1.04 [0.97-1.11],0.2546976454784709
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24821,71,0.97 [0.75-1.26],0.8179147295646608
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22835,1153,1.05 [0.98-1.12],0.1561851729591771
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26935,105,0.98 [0.79-1.21],0.8263870170730604
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24820,70,1.21 [0.94-1.56],0.1433551789323998
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25394,116,1.01 [0.83-1.24],0.9069266677212452
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25163,413,0.96 [0.86-1.06],0.4127805901057541
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27994,213,1.16 [1.00-1.34],0.0462153961823406
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25760,482,1.07 [0.97-1.18],0.1917809019854199
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28239,339,1.14 [1.02-1.29],0.023618289987392
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28324,39,0.93 [0.65-1.32],0.6831661966351334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24961,211,1.00 [0.86-1.16],0.9667734608535544
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22759,619,1.11 [1.02-1.21],0.0148830255673959
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25261,511,1.01 [0.92-1.12],0.7675034220800515
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24924,174,1.15 [0.98-1.35],0.0882811885443463
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21719,37,0.74 [0.50-1.07],0.1084979685723331
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23506,1824,1.05 [1.00-1.10],0.0689452442831475
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22148,466,0.94 [0.85-1.04],0.2291934363784323
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27869,88,1.25 [1.00-1.57],0.050865506139328
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28263,51,0.90 [0.66-1.23],0.512852862727545
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26693,30,1.13 [0.76-1.67],0.5393304818921091
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21761,79,1.01 [0.79-1.29],0.942475368557811
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25370,92,1.04 [0.83-1.30],0.7586106213559698
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22046,364,1.11 [0.99-1.24],0.0779308835586649
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25028,278,0.92 [0.80-1.04],0.1871507256154165
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25495,217,1.17 [1.01-1.35],0.0386767655816172
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25386,108,1.06 [0.86-1.31],0.5699742950564128
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,24011,50,1.14 [0.84-1.55],0.3838657055868406
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28327,42,0.87 [0.62-1.23],0.436715464596439
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25370,620,0.98 [0.90-1.07],0.6250343066793093
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27870,89,1.04 [0.82-1.30],0.7635446837572065
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27228,2478,1.02 [0.98-1.07],0.3807909433426258
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24861,111,0.97 [0.79-1.20],0.7950193386143684
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25647,369,1.05 [0.94-1.18],0.3635178832849961
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26911,189,1.01 [0.87-1.19],0.8595003603132996
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25434,156,1.00 [0.84-1.19],0.9702557310889676
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26364,1086,1.00 [0.93-1.07],0.9741126720186448
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,26002,724,0.99 [0.91-1.07],0.7699205206828598
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24797,47,1.20 [0.87-1.64],0.2629473531773111
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27930,149,1.07 [0.90-1.28],0.4412737460313618
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24910,160,0.99 [0.83-1.18],0.9283496016527988
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24810,60,0.79 [0.59-1.06],0.1163089504595154
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21721,39,1.06 [0.75-1.49],0.7468634012141888
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27760,878,1.11 [1.04-1.20],0.0036856246372952
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11514,76,1.02 [0.79-1.31],0.8785976750435581
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15297,75,0.82 [0.63-1.06],0.1284859731512959
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28036,332,1.04 [0.92-1.17],0.5099240834869784
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27765,61,0.70 [0.52-0.94],0.0159704142126393
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27593,711,1.09 [1.01-1.18],0.0310154727833358
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28148,33,0.93 [0.64-1.36],0.7156050647276007
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28155,192,1.03 [0.88-1.20],0.708472762864125
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,26071,165,1.06 [0.90-1.26],0.4722089778391726
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,26948,66,1.45 [1.13-1.86],0.0038591223326664
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12246,1158,1.01 [0.95-1.08],0.7421504029564029
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15428,206,0.91 [0.78-1.06],0.2162572261299972
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11581,143,0.97 [0.80-1.17],0.7411761533096894
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11831,393,0.88 [0.78-0.98],0.0217064813482359
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11867,429,1.02 [0.92-1.13],0.7403107722616482
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23903,4385,1.01 [0.98-1.04],0.5241928192900588
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28183,68,1.29 [1.00-1.66],0.0500675120574596
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,11176,88,0.94 [0.75-1.18],0.6007593900821727
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26792,231,1.07 [0.92-1.23],0.3801817316099816
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11856,768,1.04 [0.96-1.13],0.2944202884679181
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15283,244,0.97 [0.85-1.12],0.7161213906843291
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11195,107,1.03 [0.84-1.27],0.7651557538514713
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15300,129,0.74 [0.61-0.91],0.0039360726695218
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11737,299,0.98 [0.86-1.12],0.7824163903318424
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25976,70,0.89 [0.68-1.16],0.3919140205211016
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12891,1453,0.99 [0.94-1.05],0.8592883347726987
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11136,48,0.91 [0.67-1.25],0.5692194202655994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11544,106,1.26 [1.02-1.55],0.0311093160901535
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28330,40,1.20 [0.86-1.68],0.2899637909482832
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28336,47,0.95 [0.69-1.31],0.7658949338493477
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27455,1549,1.04 [0.98-1.10],0.1914971358579626
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26389,483,1.03 [0.93-1.14],0.5433346903231888
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15292,70,0.96 [0.73-1.25],0.741386207691624
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28287,324,1.10 [0.98-1.24],0.1189107915021387
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11242,154,0.90 [0.75-1.07],0.2213611564388375
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11209,121,1.00 [0.82-1.22],0.9937592560709936
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11166,78,1.00 [0.78-1.28],0.9950974590911092
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28304,54,1.15 [0.86-1.54],0.3560244624769432
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27028,1122,1.04 [0.97-1.11],0.2866578461394928
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15165,126,1.09 [0.90-1.32],0.3869949633477337
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11527,89,1.25 [1.00-1.57],0.0546292659583673
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11671,233,0.97 [0.84-1.12],0.6310078195156104
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11500,62,1.31 [1.00-1.72],0.0519784818234695
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11547,109,1.16 [0.94-1.42],0.173674255474099
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26824,263,1.05 [0.92-1.20],0.4745613140319644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28080,117,1.15 [0.95-1.40],0.1618983694424407
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11628,190,1.09 [0.93-1.28],0.2830039695568391
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11521,83,0.97 [0.76-1.24],0.8205610364800805
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11884,446,0.98 [0.88-1.09],0.7298908294403486
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11509,71,1.16 [0.90-1.49],0.2607592852768405
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11831,393,1.07 [0.96-1.20],0.2039731276500815
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28164,49,1.11 [0.82-1.51],0.511316935655591
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11197,109,1.17 [0.96-1.43],0.1243614385313637
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28127,1566,1.08 [1.02-1.14],0.0052657691012215
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26706,145,1.13 [0.94-1.35],0.1855926274769232
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26963,81,0.89 [0.70-1.14],0.3590217935687534
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27775,71,1.09 [0.85-1.41],0.4937953392070933
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26078,172,1.10 [0.93-1.29],0.2707399974934672
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28099,395,0.98 [0.88-1.09],0.7207160813864837
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11546,108,1.17 [0.95-1.44],0.143192785265011
